Information Provided By:
Fly News Breaks for June 6, 2017
THC, PCAR, BLUE, DNKN, COG
Jun 6, 2017 | 10:34 EDT
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cabot Oil & Gas (COG) upgraded to Outperform from Neutral at Macquarie with analyst Paul Grigel saying the pullback in shares is overdone and expects improved Natural Gas prices into the fall and tighter Marcellus differentials. 2. Dunkin' Brands (DNKN) upgraded to Buy from Hold at Argus with analyst John Staszak saying that the company, unlike most restaurant chains he covers, has "strong opportunities to expand its brand both in the U.S. and internationally." 3. bluebird bio (BLUE) upgraded to Outperform from Market Perform at BMO Capital with analyst Matthew Luchini saying that a trial of the company's bb2121 drug showed that its efficacy is "compelling," while its safety is "generally clean." 4. Paccar (PCAR) upgraded to Buy from Neutral at UBS with analyst Steven Fisher saying he expects truck production to inflect positively in the next 12 months, which should drive upside to earnings estimates. 5. Tenet (THC) upgraded to Outperform from Market Perform at Wells Fargo with analyst Gary Lieberman saying the sale of additional hospitals to HCA Holdings (HCA) could drive shares up 30%-40%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For COG;DNKN;BLUE;PCAR;THC From the Last 2 Days
THC
Mar 27, 2024 | 04:50 EDT
Wolfe Research upgraded Tenet Healthcare to Outperform from Peer Perform with a $122 price target. The analyst sees upside to estimates from the Michigan supplemental Medicaid payment increase in 2024 coupled with the company's deleveraging story. The firm confirmed that Michigan has increased its Provider Tax program by $2B for the state fiscal year 2024. Its analysis of state info and Tenet filings points to potential for a $150M to $200M benefit to the company's bottom line or approximately 6%-8% upside versus Wolfe's $2.64B 2024 EBITDA estimate.
BLUE
Mar 26, 2024 | 08:57 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - Krispy... To see the rest of the story go to thefly.com. See Story Here
PCAR
Mar 26, 2024 | 04:50 EDT
RBC Capital analyst Nick Housden initiated coverage of Paccar with a Sector Perform rating and $123 price target. The shares have rallied 77% year-over-year and on RBC's estimates, trade at a slight premium to the 10-year average, the analyst tells investors in a research note. At a time when truck demand is moving down and consensus margin expectations "appear optimistic, we do not think that now is the time to increase exposure," contends RBC.